Sulforaphane and ophthalmic diseases

被引：2
作者：
Zhang, Yichi [1 ]
Zhao, Xiaojing [1 ]
Liu, Yang [1 ]
Yang, Xiuxia [1 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Ophthalmol, Zhuhai, Peoples R China
来源：
FOOD SCIENCE & NUTRITION | 2024年 / 12卷 / 08期
基金：
英国科研创新办公室;
关键词：
age-related macular degeneration; cataract; diabetic retinopathy; ophthalmic disease; sulforaphane; RETINAL DRUG DISPOSITION; BROCCOLI SPROUTS; OXIDATIVE STRESS; ER STRESS; NRF2; TRANSCRIPTION; ACTIVATION; PREVENTS; CELLS; BIOAVAILABILITY;
D O I：
10.1002/fsn3.4230
中图分类号：
TS2 [食品工业];
学科分类号：
0832 ;
摘要：
Sulforaphane (SFN) is an organosulfur compound categorized as an isothiocyanate (ITC), primarily extracted from cruciferous vegetables like broccoli and cabbage. The molecular formula of sulforaphane (SFN) is C6H11NOS2. SFN is generated by the hydrolysis of glucoraphanin (GRP) through the enzyme myrosinase, showing notable properties including anti-diabetic, anti-inflammatory, antimicrobial, anti-angiogenic, and anticancer attributes. Ongoing clinical trials are investigating its potential in diseases such as cancer, neurodegenerative diseases, diabetes-related complications, chronic kidney disease, cardiovascular disease, and liver diseases. Several animal carcinogenesis models and cell culture models have shown it to be a very effective chemopreventive agent, and the protective effects of SFN in ophthalmic diseases have been linked to multiple mechanisms. In murine models of diabetic retinopathy and age-related macular degeneration, SFN delays retinal photoreceptor cell degeneration through the Nrf2 antioxidative pathway, NF-kappa B pathway, AMPK pathway, and Txnip/mTOR pathway. In rabbit models of keratoconus and cataract, SFN has been shown to protect corneal and lens epithelial cells from oxidative stress injury by activating the Keap1-Nrf2-ARE pathway and the Nrf-2/HO-1 antioxidant pathway. Oral delivery or intraperitoneal injection at varying concentrations are the primary strategies for SFN intake in current preclinical studies. Challenges remain in the application of SFN in eye disorders due to its weak solubility in water and limited bioavailability because of the presence of blood-ocular barrier systems. This review comprehensively outlines recent research on SFN, elucidates its mechanisms of action, and discusses potential therapeutic benefits for eye disorders such as age-related macular degeneration (AMD), diabetic retinopathy (DR), cataracts, and other ophthalmic diseases, while also indicating directions for future clinical research to achieve efficient SFN treatment for ophthalmic diseases. Sulforaphane (SFN) is an organosulfur compound categorized as an isothiocyanate (ITC), primarily extracted from cruciferous vegetables like broccoli and cabbage. This review comprehensively outlines recent research on SFN, elucidates its mechanisms of action, and discusses potential therapeutic benefits for eye disorders such as age-related macular degeneration (AMD), diabetic retinopathy (DR), cataracts, and other ophthalmic diseases, while also indicating directions for future clinical research to achieve efficient SFN treatment for ophthalmic diseases.image
引用
收藏
页码：5296 / 5311
页数：16
相关论文
共 50 条
[11]   Repairing muscle with broccoli-derived sulforaphane: A preclinical evaluation for the treatment of mitochondrial myopathies [J].
Lilley, Thomas ;
Camera, Donny M. ;
Kwa, Faith A. A. .
DRUG DISCOVERY TODAY, 2025, 30 (01)
[12]   The Pharmaceutical Properties of Sulforaphane and Its Role in Tumor and Neurodegenerative Diseases [J].
Wu, Jian-Le ;
Liu, Xi-Jian ;
Liu, Ru-Hua ;
Jiang, Feng ;
Miao, Dan .
PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2024, 51 (01) :59-69
[13]   Sulforaphane reduces obesity by reversing leptin resistance [J].
Cakir, Isin ;
Pan, Pauline Lining ;
Hadley, Colleen K. ;
El-Gamal, Abdulrahman ;
Fadel, Amina ;
Elsayegh, Dina ;
Mohamed, Omnia ;
Rizk, Nasser M. ;
Ghamari-Langroudi, Masoud .
ELIFE, 2022, 11
[14]   Pathogenetic role of magnesium deficiency in ophthalmic diseases [J].
Agarwal, Renu ;
Iezhitsa, Igor ;
Agarwal, Puneet .
BIOMETALS, 2014, 27 (01) :5-18
[15]   Pathogenetic role of magnesium deficiency in ophthalmic diseases [J].
Renu Agarwal ;
lgor Iezhitsa ;
Puneet Agarwal .
BioMetals, 2014, 27 :5-18
[16]   Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis [J].
Liu, Haoran ;
Yang, Xiaoqi ;
Tang, Kun ;
Ye, Tao ;
Duan, Chen ;
Lv, Peng ;
Yan, Libin ;
Wu, Xiaoliang ;
Chen, Zhiqiang ;
Liu, Jianhe ;
Deng, Yaoliang ;
Zeng, Guohua ;
Xing, Jinchun ;
Ye, Zhangqun ;
Xu, Hua .
THERANOSTICS, 2020, 10 (16) :7319-7334
[17]   Sulforaphane: A nutraceutical against diabetes-related complications [J].
Mthembu, Sinenhlanhla X. H. ;
Mazibuko-Mbeje, Sithandiwe E. ;
Moetlediwa, Marakiya T. ;
Muvhulawa, Ndivhuwo ;
Silvestri, Sonia ;
Orlando, Patrick ;
Nkambule, Bongani B. ;
Muller, Christo J. F. ;
Ndwandwe, Duduzile ;
Basson, Albertus K. ;
Tiano, Luca ;
V. Dludla, Phiwayinkosi .
PHARMACOLOGICAL RESEARCH, 2023, 196
[18]   Sulforaphane Glucosinolate Monograph [J].
不详 .
ALTERNATIVE MEDICINE REVIEW, 2010, 15 (04) :352-360
[19]   Sulforaphane Bioavailability and Effects on Blood Pressure in Women with Pregnancy Hypertension [J].
Langston-Cox, A. G. ;
Anderson, D. ;
Creek, D. J. ;
Palmer, K. R. ;
Marshall, S. A. ;
Wallace, E. M. .
REPRODUCTIVE SCIENCES, 2021, 28 (05) :1489-1497
[20]   Unveiling the Nutritional Veil of Sulforaphane: With a Major Focus on Glucose Homeostasis Modulation [J].
Wang, Yanan ;
He, Xiaoyun ;
Cheng, Nan ;
Huang, Kunlun .
NUTRIENTS, 2024, 16 (12)
12345